Benzimidazole compounds and their use as modulators of the...

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 401/14 (2006.01) A61K 31/415 (2006.01) A61K 31/44 (2006.01) A61K 31/495 (2006.01) C07D 235/06 (2006.01) C07D 401/10 (2006.01) C07D 403/10 (2006.01) C07D 403/14 (2006.01) C07D 405/10 (2006.01) C07D 405/14 (2006.01) C07D 409/10 (2006.01) C07D 409/14 (2006.01) C07D 413/14 (2006.01) C07D 417/10 (2006.01) C07D 417/14 (2006.01) C07D 521/00 (2006.01)

Patent

CA 2217601

The present patent application discloses compounds having the formula (see formula I) or a pharmaceutically acceptable salt thereof or an oxide thereof wherein R3 is (see formula II) wherein A, B and D each is CH, or one or two of A, B and D is N and the others are CH;~ R11 is phenyl, benzimidazolyl, or monocyclic heteroaryl all of which may be substituted one or more times with substituents selected from alkyl, halogen, CF3, amino, nitro, cyano, acylamino, alkoxy, acyl, phenyl, and monocyclic heteroaryl, and one of R6 and R7 is hydrogen and the other is pyrrolyl which may be substituted one or more times with substituents selected from halohen, alkyl, phenyl, and alkoxy. The compounds are useful for the treartment of various central nervous system disorders such as epilepsy and other convulsive disorders, anxiety, sleep disorders and memory disorders.

La présente invention décrit des composés de formule (I) ou un de leurs sels pharmaceutiquement acceptables ou un de leurs oxydes, dans laquelle R<3> est représentée par la formule (II) dans laquelle A, B et D représentent chacun CH, ou un ou deux des éléments A, B et D représentent N et les autres représentent CH; R<11> représentent phényle, benzimidazolyle, ou hétéroaryle monocyclique, chacun d'eux pouvant être substitué une ou plusieurs fois par des substituants choisis parmi alkyle, halogène, CF3, amino, nitro, cyano, acylamino, alcoxy, acyle, phényle et hétéroaryle monocyclique; et l'un parmi R<6> et R<7> représente hydrogène et l'autre représente pyrrolyle pouvant être substitué une ou plusieurs fois par des substituants choisis parmi halogène, alkyle, phényle et alcoxy. Les composés sont utilisés dans le traitement de troubles variés du système nerveux central, tels que l'épilepsie et autres troubles convulsifs, l'angoisse, les troubles du sommeil et de la mémoire.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Benzimidazole compounds and their use as modulators of the... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Benzimidazole compounds and their use as modulators of the..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Benzimidazole compounds and their use as modulators of the... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1807872

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.